Quick Answer
Aptevo Therapeutics Inc. reported Stockholders Equity of $17.38 million for fiscal year 2025.
Aptevo Therapeutics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $17.38M | +265.5% |
| 2024 | $4.75M | -61.1% |
| 2023 | $12.22M | -32.0% |
| 2022 | $17.97M | +1378.1% |
| 2021 | $1.22M | -92.7% |
| 2020 | $16.59M | +40.1% |
| 2019 | $11.84M | -61.1% |
| 2018 | $30.41M | -62.9% |
| 2017 | $82.03M | +62.2% |
| 2016 | $50.57M | -48.0% |
| 2016 | $97.20M | +8.2% |
| 2016 | $89.86M | +1.4% |
| 2015 | $88.62M | -6.3% |
| 2014 | $94.61M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.39M | +293.5% | +166.6% |
| June 30, 2025 | $6.52M | +46.2% | +542.9% |
| March 31, 2025 | -$1.47M | -124.1% | -131.0% |
| December 31, 2024 | $4.75M | -61.1% | +7.6% |
| September 30, 2024 | $4.42M | -70.0% | -1.0% |
| June 30, 2024 | $4.46M | -72.5% | -26.9% |
| March 31, 2024 | $6.10M | -73.8% | -50.1% |
| December 31, 2023 | $12.22M | -32.0% | -17.0% |
- Aptevo Therapeutics Inc. showed an increase of +265.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2014–2025 period, Aptevo Therapeutics Inc.’s stockholders equity has declined by 81.6% (from $94.61 million to $17.38 million).
- The most recent figure is from Aptevo Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: